Dexmedetomidine Dosing for Anesthesia
For a 70-kg male undergoing anesthesia, start with a loading dose of 1 μg/kg (70 μg) infused over 10 minutes, followed by a maintenance infusion of 0.2-0.7 μg/kg/hr (14-49 μg/hr), with continuous monitoring of heart rate and blood pressure throughout the procedure. 1
Loading Dose Administration
Avoid the loading dose in hemodynamically unstable patients due to risk of transient hypertension followed by hypotension and bradycardia 1. The loading dose causes biphasic cardiovascular effects: initial blood pressure elevation from peripheral α-2 receptor stimulation, followed by 10-20% decrease within 5-10 minutes from central sympathetic inhibition 1.
For hemodynamically stable patients:
- Administer 1 μg/kg (70 μg for 70-kg patient) IV over 10 minutes 1
- Onset of sedation occurs within 5-15 minutes 1
- Peak sedation achieved within 1 hour 1
Maintenance Infusion
Start at 0.2-0.7 μg/kg/hr (14-49 μg/hr for 70-kg patient) 1
Titration Strategy:
- Begin at 0.2 μg/kg/hr for procedures under 90 minutes or in patients at higher risk for hemodynamic instability 2, 3
- Increase to 0.4 μg/kg/hr if additional sedation needed, which provides optimal balance between efficacy and safety 4, 3
- Maximum approved dose: 0.7 μg/kg/hr, though doses up to 1.5 μg/kg/hr have been used safely in ICU settings 1
The maintenance rate can be adjusted based on sedation depth and hemodynamic response. Higher doses (0.6-0.75 μg/kg/hr) provide deeper sedation but increase bradycardia and hypotension risk 4, 5.
Hemodynamic Monitoring Protocol
Critical Parameters to Monitor:
Heart Rate:
- Expect 10-30% reduction from baseline 1
- Bradycardia threshold: <50 bpm - consider dose reduction or anticholinergic if symptomatic
- Most common at higher doses (0.6-0.75 μg/kg/hr) 4, 5
Blood Pressure:
- Anticipate 10-20% decrease in mean arterial pressure 1
- Hypotension more likely with doses >0.5 μg/kg/hr 3
- Hypertensive patients show greater blood pressure reduction (median 45 vs 28 mmHg in normotensive) 6
Respiratory Function:
- Minimal respiratory depression compared to other sedatives 1
- Monitor for loss of oropharyngeal muscle tone causing airway obstruction 1
- Supplemental oxygen rarely needed (8.7% of cases) 6
Important Clinical Considerations
Anesthetic-Sparing Effects:
- Reduces inhalational anesthetic requirements by 40-60% 1
- Decreases opioid needs by 25-40% 7, 4
- Lowers propofol induction dose requirements 8
Hepatic Dysfunction:
Reduce maintenance dose in severe hepatic impairment due to prolonged elimination half-life (normally ~3 hours) 1
Common Pitfalls to Avoid:
Do not routinely co-administer anticholinergics - increases arrhythmia risk, especially second-degree AV block, when given simultaneously or after dexmedetomidine 1
Avoid rapid bolus administration - causes pronounced hemodynamic instability 1
Do not use loading dose in critically ill or hemodynamically unstable patients - start directly with maintenance infusion 1